KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Assets: 2018-2024

Historic Current Assets for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $283.8 million.

  • Adaptive Biotechnologies' Current Assets fell 8.73% to $281.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $281.4 million, marking a year-over-year decrease of 8.73%. This contributed to the annual value of $283.8 million for FY2024, which is 30.82% down from last year.
  • As of FY2024, Adaptive Biotechnologies' Current Assets stood at $283.8 million, which was down 30.82% from $410.2 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Current Assets ranged from a high of $726.9 million in FY2020 and a low of $283.8 million during FY2024.
  • For the 3-year period, Adaptive Biotechnologies' Current Assets averaged around $418.7 million, with its median value being $410.2 million (2023).
  • As far as peak fluctuations go, Adaptive Biotechnologies' Current Assets plummeted by 44.59% in 2021, and later surged by 39.58% in 2022.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Current Assets stood at $726.9 million in 2020, then crashed by 44.59% to $402.7 million in 2021, then soared by 39.58% to $562.1 million in 2022, then declined by 27.03% to $410.2 million in 2023, then plummeted by 30.82% to $283.8 million in 2024.